Institutional Ownership
Regeneron Pharmaceuticals
CUSIP 75886F107COMREGNQ1 2026
13D / 13G Filings
31
Schedule 13D/13G on record
Beneficial Filers
7
Distinct reporting persons
Largest Stake
21.0%
Max % of class reported
Institutional Holders
1,374
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
31 filings · latest Aug 6, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Aug 6, 2025 | Fmr LLC | 13G/A | 3.2% | 3.36M | SEC |
| 2 | Jun 5, 2025 | Jpmorgan Chase &Amp; Co. | 13G/A | 4.4% | 4.74M | SEC |
| 3 | Apr 22, 2025 | Jpmorgan Chase &Amp; Co. | 13G/A | 5.1% | 5.55M | SEC |
| 4 | Feb 12, 2025 | Fmr LLC | 13G/A | 7.6% | 8.19M | SEC |
| 5 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 8.3% | 8.84M | SEC |
| 6 | Feb 9, 2024 | Capital World Investors | 13G/A | 4.8% | 5.19M | SEC |
| 7 | Feb 9, 2024 | Fmr LLC | 13G/A | 9.6% | — | SEC |
| 8 | Jan 25, 2024 | Blackrock Inc. | 13G/A | 8.1% | 8.63M | SEC |
| 9 | Jan 25, 2024 | Jpmorgan Chase & Co | 13G/A | 6.7% | 7.22M | SEC |
| 10 | Jan 25, 2024 | Jpmorgan Chase & Co | 13G/A | 6.7% | 7.22M | SEC |
21 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Regeneron Pharmaceuticals.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 8.95M | $6.91B |
| 2 | State Street Corp | 4.66M | $3.60B |
| 3 | Dodge & Cox | 4.46M | $3.44B |
| 4 | Jpmorgan Chase & Co | 4.31M | $3.23B |
| 5 | Franklin Resources Inc | 2.72M | $2.10B |
| 6 | Geode Capital Management, LLC | 2.61M | $2.01B |
| 7 | Nuveen, LLC | 2.07M | $1.60B |
| 8 | Loomis Sayles & Co L P | 1.91M | $1.48B |
| 9 | Wellington Management Group LLP | 1.84M | $1.42B |
| 10 | Invesco Ltd. | 1.72M | $1.33B |